Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_assertion type Assertion NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_head.
- NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_assertion wasGeneratedBy ECO_0000203 NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_provenance.
- NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_assertion wasDerivedFrom befree-20140225 NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_provenance.
- NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_assertion SIO_000772 15300803 NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_provenance.
- NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_assertion evidence source_evidence_literature NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_provenance.
- NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_assertion description "[Our study strongly supports the use of Ad-CD40L and Ad-IL-2 combination therapy for the treatment of patients with B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350041.RAqvE_A_MyJtkSUAykJhY8N1MEOgNSBx2tcYRRZzLeMuQ130_provenance.